The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Grodnitskaia E.É.

Tsentr planirovaniia sem'i i reproduktsii Departamenta zdravookhraneniia, Moskva

Kurtser M.A.

Tsentr planirovaniia sem'i i reproduktsii DZ Moskvy

Melnichenko G.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia;
Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia

Dedov I.I.

Endocrinology Research Centre

The polycystic ovary syndrome in patients with diabetes mellitus type i

Authors:

Grigorian O.R., Grodnitskaia E.É., Kurtser M.A., Melnichenko G.A., Dedov I.I.

More about the authors

Read: 4128 times


To cite this article:

Grigorian OR, Grodnitskaia EÉ, Kurtser MA, Melnichenko GA, Dedov II. The polycystic ovary syndrome in patients with diabetes mellitus type i. Russian Journal of Human Reproduction. 2012;(3):34‑36. (In Russ.)

Recommended articles:
Reproductive function in patients with signs of poly­cystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(6):60-69
«Metabolic health» and endo­thelial function in women with poly­cystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):27-34

References:

  1. Codner E., Mook-Kanamori D., Bazaes R.A., Unanue N., Sovino H., Ugarte F., Avila A., Iniguez G., Cassorla F. Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 2005; 90: 3939-3945.
  2. Codner E., Soto N., Lopez P., Trejo L., Avila A., Eyzaguirre F. C., Iniguez G., Cassorla F. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 2250-2256.
  3. Djursing H., Nyholm H.C., Hagen C., Carstensen L., Pedersen L.M. Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus. Am J Obstet Gynecol 1982; 143: 876-882.
  4. Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-353.
  5. Ehrmann D.A., Rosenfield R.L., Barnes R.B., Brigell D.F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992; 327: 157-162.
  6. Escobar-Morreale H.F., Roldan B., Barrio R., Alonso M., Sancho J., de la Calle H., Garcia-Robles R. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2000; 85: 4182-4187.
  7. Pedersen O., Beck-Nielsen H. Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care 1987; 10: 516-523.
  8. Roldan B., Escobar-Morreale H.F., Barrio R., de La Calle H., Alonso M., Garcia-Robles R., Sancho J. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care 2001; 24: 1297-1299.
  9. Rosenfield R.L. Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved. J Clin Endocrinol Metab 1996; 81: 878-880.
  10. Rudberg S., Persson B. Indications of low sex hormone binding globulin (SHBG) in young females with type 1 diabetes, and an independent association to microalbuminuria. Diabet Med 1995; 12: 816-822.
  11. Salley K.E., Wickham E.P., Cheang K.I., Essah P.A., Karjane N.W., Nestler J.E. Glucose intolerance in polycystic ovary syndrome - a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007; 92: 12: 4546-4556.
  12. The Diabetes Control, Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
  13. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
  14. Virdis R., Zampolli M., Street M. E., Vanelli M., Potau N., Terzi C., Ghizzoni L., Ibanez L. Ovarian 17-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic adolescents. Eur J Endocrinol 1997; 136: 624-629.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.